CALQUENCE vs IMBRUVICA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. CALQUENCE and IMBRUVICA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CALQUENCE	IMBRUVICA
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ACALABRUTINIB	IBRUTINIB
Manufacturer	Astrazeneca	Pharmacyclics LLC
Dosage forms	Capsule, Tablet	Capsule, Suspension, Tablet
Drug class	Kinase Inhibitor	—
Boxed warning	None	None
Treats	Mantle-Cell Lymphoma	Waldenstrom Macroglobulinemia, B-Cell Chronic Lymphocytic Leukemia, B-Cell Lymphoma

calquence imbruvica

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

ACALABRUTINIB

IBRUTINIB

Manufacturer

Astrazeneca

Pharmacyclics LLC

Dosage forms

Capsule, Tablet

Capsule, Suspension, Tablet

Drug class

Kinase Inhibitor

—

Boxed warning

None

Treats

Mantle-Cell Lymphoma

Waldenstrom Macroglobulinemia, B-Cell Chronic Lymphocytic Leukemia, B-Cell Lymphoma

Frequently asked questions

What is the difference between Calquence and Imbruvica?

Calquence contains Acalabrutinib, while Imbruvica contains Ibrutinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.